Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2011

01-11-2011 | Original Research

Cultural, Economic, and Psychological Predictors of Colonoscopy in a National Sample

Authors: Chanita Hughes Halbert, PhD, Frances K. Barg, PhD, Carmen E. Guerra, MD, Judy A. Shea, PhD, Katrina Armstrong, MD, Monica Ferguson, MD, Benita Weathers, MPH, James Coyne, PhD, Andrea B. Troxel, ScD

Published in: Journal of General Internal Medicine | Issue 11/2011

Login to get access

Abstract

Background

Although colorectal cancer (CRC) is the second leading cause of cancer death among adults in the US and colonoscopy is efficacious in reducing morbidity and mortality from CRC, screening rates are sub-optimal. Understanding the socioeconomic, cultural, and health care context within which decisions about colonoscopy are made allows physicians to address patients’ most salient beliefs and values and other constraints when making screening recommendations.

Objective

To evaluate the direct and interactive effects of socioeconomics, health care variables, psychological characteristics, and cultural values on colonoscopy use.

Design, Setting, Participants

National survey completed between January-August 2009 in a random sample of African American, white, and Hispanic adults ages 50–75 without cancer (n = 582).

Main Measure

Self-reported colonoscopy use.

Key Results

Only 59% of respondents reported having a colonoscopy. The likelihood of colonoscopy increased with having health insurance (OR = 2.82, 95% CI = 1.24, 6.43, p = 0.004), and increasing age (OR = 1.40, 95% CI = 1.11, 1.77, p = 0.001). In addition, respondents with greater self-efficacy were more likely to have a colonoscopy (OR = 2.41, 95% CI = 1.35, 4.29, p = 0.003).

Conclusions

Programs that help patients to overcome access and psychological barriers to screening are needed.
Literature
1.
go back to reference American Cancer Society. Cancer Prevention and Early Detection Facts and Figures 2010. Atlanta: American Cancer Society; 2010. American Cancer Society. Cancer Prevention and Early Detection Facts and Figures 2010. Atlanta: American Cancer Society; 2010.
2.
go back to reference Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160.PubMedCrossRef Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160.PubMedCrossRef
3.
go back to reference Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMedCrossRef Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMedCrossRef
4.
go back to reference Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–658.PubMed Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–658.PubMed
5.
go back to reference Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.PubMed Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.PubMed
6.
7.
go back to reference Vital signs: colorectal cancer screening among adults aged 50–75 years - United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59:808–812. Vital signs: colorectal cancer screening among adults aged 50–75 years - United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59:808–812.
8.
go back to reference Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED. Colorectal cancer screening in 3 racial groups. Am J Health Behav. 2007;31:502–513.PubMed Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED. Colorectal cancer screening in 3 racial groups. Am J Health Behav. 2007;31:502–513.PubMed
9.
go back to reference Wong N. Investigating the effects of cancer risk and efficacy perceptions on cancer prevention adherence and intentions. Health Commun. 2009;24:95–105.PubMedCrossRef Wong N. Investigating the effects of cancer risk and efficacy perceptions on cancer prevention adherence and intentions. Health Commun. 2009;24:95–105.PubMedCrossRef
10.
go back to reference Kreuter MW, Lukwago SN, Bucholtz RD, Clark EM, Sanders-Thompson V. Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches. Health Educ Behav. 2003;30:133–146.PubMedCrossRef Kreuter MW, Lukwago SN, Bucholtz RD, Clark EM, Sanders-Thompson V. Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches. Health Educ Behav. 2003;30:133–146.PubMedCrossRef
11.
go back to reference Lannin DR, Mathews HF, Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279:1801–1807.PubMedCrossRef Lannin DR, Mathews HF, Mitchell J, et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279:1801–1807.PubMedCrossRef
12.
go back to reference Kinney AY, Bloor LE, Martin C, Sandler RS. Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev. 2005;14:182–189.PubMed Kinney AY, Bloor LE, Martin C, Sandler RS. Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev. 2005;14:182–189.PubMed
13.
go back to reference Kagawa-Singer M, Dadia AV, Yu MC, Surbone A. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60:12–39.PubMedCrossRef Kagawa-Singer M, Dadia AV, Yu MC, Surbone A. Cancer, culture, and health disparities: time to chart a new course? CA Cancer J Clin. 2010;60:12–39.PubMedCrossRef
14.
go back to reference Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981.PubMedCrossRef Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981.PubMedCrossRef
15.
go back to reference Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.PubMed Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.PubMed
16.
go back to reference Klabunde CN, Lanier D, Nadel MR, et al. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med. 2009;37:8–16.PubMedCrossRef Klabunde CN, Lanier D, Nadel MR, et al. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med. 2009;37:8–16.PubMedCrossRef
17.
go back to reference Guerra CE, Schwartz JS, Armstrong K, et al. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22:1681–1688.PubMedCrossRef Guerra CE, Schwartz JS, Armstrong K, et al. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22:1681–1688.PubMedCrossRef
18.
go back to reference Schenck AP, Peacock SC, Klabunde CN, et al. Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med. 2009;37:1–7.PubMedCrossRef Schenck AP, Peacock SC, Klabunde CN, et al. Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med. 2009;37:1–7.PubMedCrossRef
19.
go back to reference Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41.PubMedCrossRef Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41.PubMedCrossRef
20.
go back to reference The American Association for Public Opinion Research. 2011. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 7th edition. AAPOR. The American Association for Public Opinion Research. 2011. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 7th edition. AAPOR.
22.
go back to reference Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229–232.PubMed Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev. 2000;9:229–232.PubMed
23.
go back to reference Aiken L, West S. Multiple Regression: Testing and Interpreting Interactions. Thousand Oaks: Sage; 1991. Aiken L, West S. Multiple Regression: Testing and Interpreting Interactions. Thousand Oaks: Sage; 1991.
24.
go back to reference Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
25.
go back to reference White A, Vernon SW, Franzini L, Du, XL. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare’s screening reimbursement. Cancer Epidemiol Biomarkers Prev. 2011;20:811–817.PubMedCrossRef White A, Vernon SW, Franzini L, Du, XL. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare’s screening reimbursement. Cancer Epidemiol Biomarkers Prev. 2011;20:811–817.PubMedCrossRef
26.
go back to reference Crawford ND, Jones CP, Richardson LC. Understanding racial and ethnic disparities in colorectal cancer screening: behavioral risk factor surveillance system, 2002 and 2004. Ethn Dis. 2010;20:359–365.PubMed Crawford ND, Jones CP, Richardson LC. Understanding racial and ethnic disparities in colorectal cancer screening: behavioral risk factor surveillance system, 2002 and 2004. Ethn Dis. 2010;20:359–365.PubMed
27.
go back to reference Rim SH, Joseph DA, Steele CB. Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR. 2011;60:42–46.PubMed Rim SH, Joseph DA, Steele CB. Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR. 2011;60:42–46.PubMed
29.
go back to reference McQueen A, Vernon SW, Rothman AJ, et al. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med. 2010;40:205–217.PubMedCrossRef McQueen A, Vernon SW, Rothman AJ, et al. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med. 2010;40:205–217.PubMedCrossRef
30.
go back to reference Pargament KI, Koenig HG, Perez LM. The many methods of religious coping: development and initial validation of the RCOPE. J Clin Psychol. 2000;56:519–543.PubMedCrossRef Pargament KI, Koenig HG, Perez LM. The many methods of religious coping: development and initial validation of the RCOPE. J Clin Psychol. 2000;56:519–543.PubMedCrossRef
31.
go back to reference Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010; 152:668–676.PubMed Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010; 152:668–676.PubMed
32.
go back to reference Christie J, Itzkowitz S, Lihau-Nkanza I, et al. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008;100;278–284.PubMed Christie J, Itzkowitz S, Lihau-Nkanza I, et al. A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities. J Natl Med Assoc. 2008;100;278–284.PubMed
33.
go back to reference Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients. Arch Intern Med. 2011;171:906–912.PubMedCrossRef Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients. Arch Intern Med. 2011;171:906–912.PubMedCrossRef
Metadata
Title
Cultural, Economic, and Psychological Predictors of Colonoscopy in a National Sample
Authors
Chanita Hughes Halbert, PhD
Frances K. Barg, PhD
Carmen E. Guerra, MD
Judy A. Shea, PhD
Katrina Armstrong, MD
Monica Ferguson, MD
Benita Weathers, MPH
James Coyne, PhD
Andrea B. Troxel, ScD
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 11/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1783-9

Other articles of this Issue 11/2011

Journal of General Internal Medicine 11/2011 Go to the issue

Healing Arts: Materia Medica

History

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.